CLINICAL_TRIALS trial_result · 2015-06-17

Clinical Trial Update: Placebo Controlled Metformin and Sulfonylurea Combination Study in Patients With Type 2 Diabetes (0767-025) [Phase 3]

Phase 3 trial of placebo-controlled metformin with a sulfonylurea combination in Type 2 diabetes was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED